[go: up one dir, main page]

NZ713235A - Product and method for improving bioavailability of therapeutic compounds - Google Patents

Product and method for improving bioavailability of therapeutic compounds

Info

Publication number
NZ713235A
NZ713235A NZ713235A NZ71323514A NZ713235A NZ 713235 A NZ713235 A NZ 713235A NZ 713235 A NZ713235 A NZ 713235A NZ 71323514 A NZ71323514 A NZ 71323514A NZ 713235 A NZ713235 A NZ 713235A
Authority
NZ
New Zealand
Prior art keywords
product
therapeutic compounds
improving bioavailability
bioavailability
improving
Prior art date
Application number
NZ713235A
Inventor
Brent Petersen
Melinda Moss
Niels Palmer
Original Assignee
Glanbia Nutritionals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51530032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ713235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glanbia Nutritionals Ireland Ltd filed Critical Glanbia Nutritionals Ireland Ltd
Publication of NZ713235A publication Critical patent/NZ713235A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1276—Globules of milk; Constituents thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)

Abstract

Disclosed is a method for improving the bioavailability of a variety of compounds such as phenolic acids, polyphenols, hydroxyl-cinnamic acids, curcumin, curcumin analogs, curcuminoids, etc., using milk protein concentrate and/or similar milk protein products.
NZ713235A 2013-03-15 2014-03-17 Product and method for improving bioavailability of therapeutic compounds NZ713235A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361788200P 2013-03-15 2013-03-15
PCT/US2014/030685 WO2014145851A1 (en) 2013-03-15 2014-03-17 Product and method for improving bioavailability of therapeutic compounds

Publications (1)

Publication Number Publication Date
NZ713235A true NZ713235A (en) 2019-12-20

Family

ID=51530032

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ713235A NZ713235A (en) 2013-03-15 2014-03-17 Product and method for improving bioavailability of therapeutic compounds

Country Status (8)

Country Link
US (1) US9452146B2 (en)
EP (1) EP2968070B1 (en)
JP (2) JP6548632B2 (en)
CN (1) CN105491988A (en)
AU (1) AU2014232456B2 (en)
CA (1) CA2911020A1 (en)
NZ (1) NZ713235A (en)
WO (1) WO2014145851A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ713235A (en) 2013-03-15 2019-12-20 Glanbia Nutritionals Ireland Ltd Product and method for improving bioavailability of therapeutic compounds
CN114246849A (en) * 2014-05-12 2022-03-29 奥斯生化药剂公司 Curcumin-peptide conjugates and formulations thereof
US10188135B2 (en) 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
CN109419795B (en) * 2017-08-28 2021-02-26 四川九章生物科技有限公司 Combined medicine for treating tumor necrosis factor family related diseases
KR20240008350A (en) * 2021-05-19 2024-01-18 아를라 푸즈 에이엠비에이 High-protein micellar casein-containing nutrient solution rich in catechin compounds and production method

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK546289D0 (en) * 1989-11-02 1989-11-02 Danochemo As carotenoid
EP0748591B1 (en) * 1995-06-16 2001-10-17 Societe Des Produits Nestle S.A. Fluorinated micellar casein
DE19919751A1 (en) 1999-04-29 2000-11-09 Basf Ag Stable, aqueous dispersions and stable, water-dispersible dry powder of xanthophylls, their preparation and use
JP2005508939A (en) 2001-10-12 2005-04-07 エラン ファーマ インターナショナル，リミティド Composition having combined immediate release and sustained release characteristics
US6923995B2 (en) * 2002-03-27 2005-08-02 Jay C. Highman Rice protein concentrate based organic nutritional formula
BRPI0618870A2 (en) 2005-11-22 2011-09-13 Nestec Sa oil-in-water emulsion and its use for the distribution of functionality
EP1839498B1 (en) 2006-03-27 2011-04-27 Nestec S.A. Whey protein vehicle for active agent delivery
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility
WO2008017415A1 (en) * 2006-08-09 2008-02-14 Dsm Ip Assets B.V. Casein complexes
JP5289310B2 (en) 2007-05-15 2013-09-11 国立大学法人名古屋大学 Microtubule disrupting agent and cancer cell growth inhibitor containing the same
JP2009040722A (en) * 2007-08-09 2009-02-26 Fujifilm Corp Casein nano particles consisting of multiple number of protein
US8871276B2 (en) 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
US8865222B2 (en) 2008-02-11 2014-10-21 Technion Research And Development Foundation Ltd. Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof
US20110045092A1 (en) 2008-02-11 2011-02-24 Livney Yoav D Casein particles encapsulating therapeutically active agents and uses thereof
WO2009101613A1 (en) 2008-02-11 2009-08-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
CN101816418B (en) * 2009-11-24 2012-07-18 北京三元食品股份有限公司 Probiotic microcapsules and preparation method thereof
WO2011100983A1 (en) * 2010-02-17 2011-08-25 El-Sayed Ameen Mahmoud Rezq Casein, a novel curcumin drug carrier system
WO2011104410A1 (en) * 2010-02-26 2011-09-01 Instituto Científico Y Tecnológico De Navarra, S.A. Nanoparticles for the encapsulation of compounds, preparation thereof and use of same
CN102126938B (en) * 2010-12-15 2013-03-27 厦门大学 Curcumin analog and preparation method and application thereof
CN102600063B (en) * 2011-06-09 2013-10-23 天津大学 A kind of preparation method of curcumin micelles with high drug load
CN102512404B (en) 2011-11-18 2014-05-07 上海交通大学 Lung targeting preparation of curcumin class compound as well as preparation method and application thereof
CN102743336A (en) * 2012-07-04 2012-10-24 浙江大学 Preparation method and application of curcumin chitosan-stearic acid graft micelle
NZ713235A (en) 2013-03-15 2019-12-20 Glanbia Nutritionals Ireland Ltd Product and method for improving bioavailability of therapeutic compounds

Also Published As

Publication number Publication date
EP2968070A4 (en) 2016-10-26
US9452146B2 (en) 2016-09-27
EP2968070A1 (en) 2016-01-20
US20140275283A1 (en) 2014-09-18
CA2911020A1 (en) 2014-09-18
CN105491988A (en) 2016-04-13
AU2014232456B2 (en) 2018-11-15
JP2016515535A (en) 2016-05-30
AU2014232456A1 (en) 2015-11-05
WO2014145851A1 (en) 2014-09-18
EP2968070B1 (en) 2019-12-18
JP2019077699A (en) 2019-05-23
JP6548632B2 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
EP3131406A4 (en) Plant based meat structured protein products
EP3032961A4 (en) System, machine and method for the preparation of cooled edible products
EP3188605A4 (en) Preparation of pulse protein products ("yp810")
EP3166612A4 (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
WO2014131422A3 (en) Fermented rapeseed feed ingredient
MX2020009444A (en) Low dose oral pharmaceutical composition of isotretinoin.
NZ713235A (en) Product and method for improving bioavailability of therapeutic compounds
ZA201702085B (en) Preparation of soy protein products ("s810")
ZA201804783B (en) Process for the preparation of 4-alkoxy-3-acetoxypicolinic acids
WO2016080796A3 (en) Pharmaceutical composition, containing sesquiterpene compound, for preventing or treating stat3-mediated diseases, and use thereof
EP3166928A4 (en) Process for the preparation of 3-hydroxypicolinic acids
MX2021000508A (en) Dry, flowable sabadilla extract.
IL256007A (en) Enzyme-treated milk product, preparation method thereof, composition, and products
EP3422855A4 (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
EP3441076A4 (en) Pharmaceutical product for treating tumor and combined immune defect, and preparation and application thereof
EP3097918A4 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
ZA201804877B (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
EP3527089A4 (en) Leg product
FR3018075B1 (en) PROCESS FOR THE PREPARATION OF 2,4-DIAMINO-3-HYDROXYBUTYRIC ACID DERIVATIVES
EP3676272A4 (en) Process for the preparation of ixazomib citrate
MX2021000509A (en) Concentrated sabadilla extract.
IL250260A0 (en) Process for the preparation of 4,5,6-trichloropicolinic acid
EP3227260A4 (en) Process for the preparation of levulinic acid
EP3148977A4 (en) Process for the preparation of 4-dimethylaminocrotonic acid

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed